GlassScriptPhysician profile
Mureema M Solberg
NPI 1609812064
$9,285.63
in general payments reported to CMS, 2019-2025
54 companies · $1,184 in 2025
The $1,184 reported for 2025 was more than what 89% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,685 · 2020: $1,024 · 2021: $1,746 · 2022: $1,474 · 2023: $1,148 · 2024: $1,025 · 2025: $1,184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,338 · Education: $18.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,338.14 |
| Education | $18.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,067.28 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $850.14 | 2019-2025 | Jardiance |
| Novo Nordisk INC | $700.68 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $547.64 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Abbvie INC. | $543.48 | 2019-2025 | Vraylar, Ubrelvy |
| Lilly USA, LLC | $466.06 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Sanofi-Aventis U.S. LLC | $392.38 | 2019-2024 | |
| Amgen INC. | $379.48 | 2019-2024 | Evenity, Prolia |
| Glaxosmithkline, LLC. | $365.44 | 2019-2025 | Shingrix |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $352.67 | 2019-2025 | Xifaxan, Trulance |
| Janssen Pharmaceuticals, INC | $347.89 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $326.62 | 2019-2022 | |
| Astellas Pharma US INC | $325.17 | 2019-2025 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $300.77 | 2021-2024 | |
| Allergan, INC. | $274.49 | 2019-2020 |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mureema Solberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.